share_log

AbbVie | SD: Specialized disclosure report

AbbVie | SD: Specialized disclosure report

艾伯维公司 | SD:专项披露公告
美股sec公告 ·  05/31 16:11
Moomoo AI 已提取核心信息
AbbVie Inc., a biopharmaceutical company, has filed its Specialized Disclosure Report (Form SD) with the U.S. Securities and Exchange Commission (SEC) for the reporting period from January 1 to December 31, 2023. The report, which is required under Rule 13p-1 of the Securities Exchange Act, includes the company's Conflict Minerals Report as Exhibit 1.01. This report details AbbVie's due diligence regarding the source and chain of custody of conflict minerals used in their products. The Conflict Minerals Report is also available on AbbVie's investor relations website. The filing, signed by Scott T. Reents on May 31, 2024, does not apply to the Resource Extraction Issuer Disclosure, which is not applicable to the company.
AbbVie Inc., a biopharmaceutical company, has filed its Specialized Disclosure Report (Form SD) with the U.S. Securities and Exchange Commission (SEC) for the reporting period from January 1 to December 31, 2023. The report, which is required under Rule 13p-1 of the Securities Exchange Act, includes the company's Conflict Minerals Report as Exhibit 1.01. This report details AbbVie's due diligence regarding the source and chain of custody of conflict minerals used in their products. The Conflict Minerals Report is also available on AbbVie's investor relations website. The filing, signed by Scott T. Reents on May 31, 2024, does not apply to the Resource Extraction Issuer Disclosure, which is not applicable to the company.
生物制药公司艾伯维公司已向美国证券交易委员会(SEC)提交了2023年1月1日至12月31日报告期的专业披露报告(SD表格)。根据《证券交易法》第13p-1条的规定,该报告将公司的冲突矿产报告列为附录1.01。本报告详细介绍了艾伯维对其产品中使用的冲突矿产的来源和监管链的尽职调查。《冲突矿产报告》也可在艾伯维的投资者关系网站上查阅。该文件由斯科特·雷恩斯于2024年5月31日签署,不适用于资源开采发行人披露声明,该披露不适用于该公司。
生物制药公司艾伯维公司已向美国证券交易委员会(SEC)提交了2023年1月1日至12月31日报告期的专业披露报告(SD表格)。根据《证券交易法》第13p-1条的规定,该报告将公司的冲突矿产报告列为附录1.01。本报告详细介绍了艾伯维对其产品中使用的冲突矿产的来源和监管链的尽职调查。《冲突矿产报告》也可在艾伯维的投资者关系网站上查阅。该文件由斯科特·雷恩斯于2024年5月31日签署,不适用于资源开采发行人披露声明,该披露不适用于该公司。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息